SCHEMBL473917

SCHEMBL473917

COC(=O)c1ccc(-c2ccccc2)c(C(C)C(O)(c2ccc3oc(=O)n(C)c3c2)C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
TSHR P16473 1/20 0.36
HPGD P15428 2/20 0.36
NPC1 O15118 1/20 0.35
EGFR P00533 1/20 0.35
PTGS2 P35354 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ASAH1 Q13510 1/20 0.35
KMO O15229 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA3 P34903 1/20 0.34
POLB P06746 1/20 0.34
PDK2 Q15119 1/20 0.33
GLA P06280 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473993 0.92 MAPK14 (0.40) ALDH1A1TSHRASAH1KMO
SCHEMBL474051 0.91 ALDH1A1 (0.39) ALDH1A1HPGDMEN1KMT2AASAH1
SCHEMBL473904 0.85 ALDH1A1 (0.46) ALDH1A1TSHRHPGDMEN1KMT2A
SCHEMBL474023 0.84 PDK1 (0.40) ALDH1A1TSHRHPGDMEN1KMT2A
SCHEMBL473839 0.83 RORC (0.35) ALDH1A1TSHRPOLBPDK2
SCHEMBL12164104 0.83 RORC (0.35) ALDH1A1TSHRPOLBPDK2
SCHEMBL474394 0.79 POLB (0.36) ALDH1A1EGFRPTGS2POLBPDK2
SCHEMBL474057 0.78 KMO (0.36) ALDH1A1HPGDASAH1KMOSMN1; SMN2
SCHEMBL12164107 0.77 KCNJ1 (0.39) ALDH1A1TSHRPDK2
SCHEMBL473863 0.77 KCNJ1 (0.39) ALDH1A1TSHRPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed